vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and SHORE BANCSHARES INC (SHBI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $59.1M, roughly 1.3× SHORE BANCSHARES INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 11.8%). SHORE BANCSHARES INC produced more free cash flow last quarter ($59.2M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 11.3%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Shore Bancshares Inc. is a U.S. regional bank holding company headquartered in Maryland. It offers a full range of retail and commercial banking services, including deposit products, personal and commercial loans, and wealth management solutions, primarily serving local individual customers, small businesses and mid-sized enterprises in its operating regions.
PBYI vs SHBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $59.1M |
| Net Profit | — | — |
| Gross Margin | 69.3% | — |
| Operating Margin | 22.7% | 35.2% |
| Net Margin | — | — |
| Revenue YoY | 27.7% | 11.8% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.26 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $59.1M | ||
| Q3 25 | $54.5M | $56.4M | ||
| Q2 25 | $52.4M | $56.6M | ||
| Q1 25 | $46.0M | $53.0M | ||
| Q4 24 | $59.1M | $52.9M | ||
| Q3 24 | $80.5M | $50.5M | ||
| Q2 24 | $47.1M | $50.6M | ||
| Q1 24 | $43.8M | $47.7M |
| Q4 25 | — | — | ||
| Q3 25 | $8.8M | $14.3M | ||
| Q2 25 | $5.9M | $15.5M | ||
| Q1 25 | $3.0M | $13.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | $11.2M | ||
| Q2 24 | $-4.5M | $11.2M | ||
| Q1 24 | $-4.8M | $8.2M |
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
| Q4 25 | 22.7% | 35.2% | ||
| Q3 25 | 17.6% | 33.7% | ||
| Q2 25 | 12.7% | 36.5% | ||
| Q1 25 | 8.7% | 34.4% | ||
| Q4 24 | 22.6% | 34.3% | ||
| Q3 24 | 27.4% | 29.6% | ||
| Q2 24 | -4.6% | 29.7% | ||
| Q1 24 | -5.3% | 22.2% |
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | 25.5% | ||
| Q2 25 | 11.2% | 27.4% | ||
| Q1 25 | 6.5% | 26.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | 22.1% | ||
| Q2 24 | -9.6% | 22.2% | ||
| Q1 24 | -11.0% | 17.2% |
| Q4 25 | $0.26 | $0.48 | ||
| Q3 25 | $0.17 | $0.43 | ||
| Q2 25 | $0.12 | $0.46 | ||
| Q1 25 | $0.06 | $0.41 | ||
| Q4 24 | $0.40 | $0.39 | ||
| Q3 24 | $0.41 | $0.34 | ||
| Q2 24 | $-0.09 | $0.34 | ||
| Q1 24 | $-0.10 | $0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $355.6M |
| Total DebtLower is stronger | $22.7M | $89.1M |
| Stockholders' EquityBook value | $130.3M | $589.9M |
| Total Assets | $216.3M | $6.3B |
| Debt / EquityLower = less leverage | 0.17× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $355.6M | ||
| Q3 25 | $94.4M | $416.5M | ||
| Q2 25 | $96.0M | $185.0M | ||
| Q1 25 | $93.2M | $389.0M | ||
| Q4 24 | $101.0M | $459.9M | ||
| Q3 24 | $96.7M | $183.6M | ||
| Q2 24 | $96.8M | $138.9M | ||
| Q1 24 | $107.2M | $114.6M |
| Q4 25 | $22.7M | $89.1M | ||
| Q3 25 | $34.0M | $74.5M | ||
| Q2 25 | $45.3M | $74.2M | ||
| Q1 25 | $56.7M | $74.0M | ||
| Q4 24 | $68.0M | $73.7M | ||
| Q3 24 | $79.3M | $123.5M | ||
| Q2 24 | $90.7M | $122.8M | ||
| Q1 24 | $102.0M | $72.6M |
| Q4 25 | $130.3M | $589.9M | ||
| Q3 25 | $115.3M | $577.2M | ||
| Q2 25 | $104.7M | $565.2M | ||
| Q1 25 | $97.1M | $552.5M | ||
| Q4 24 | $92.1M | $541.1M | ||
| Q3 24 | $71.1M | $533.3M | ||
| Q2 24 | $48.5M | $522.8M | ||
| Q1 24 | $51.0M | $515.2M |
| Q4 25 | $216.3M | $6.3B | ||
| Q3 25 | $202.9M | $6.3B | ||
| Q2 25 | $194.9M | $6.0B | ||
| Q1 25 | $196.2M | $6.2B | ||
| Q4 24 | $213.3M | $6.2B | ||
| Q3 24 | $220.7M | $5.9B | ||
| Q2 24 | $205.0M | $5.9B | ||
| Q1 24 | $214.1M | $5.8B |
| Q4 25 | 0.17× | 0.15× | ||
| Q3 25 | 0.30× | 0.13× | ||
| Q2 25 | 0.43× | 0.13× | ||
| Q1 25 | 0.58× | 0.13× | ||
| Q4 24 | 0.74× | 0.14× | ||
| Q3 24 | 1.12× | 0.23× | ||
| Q2 24 | 1.87× | 0.23× | ||
| Q1 24 | 2.00× | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $62.4M |
| Free Cash FlowOCF − Capex | $14.4M | $59.2M |
| FCF MarginFCF / Revenue | 19.1% | 100.2% |
| Capex IntensityCapex / Revenue | 0.0% | 5.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $110.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $62.4M | ||
| Q3 25 | $9.7M | $42.5M | ||
| Q2 25 | $14.1M | $-8.3M | ||
| Q1 25 | $3.6M | $19.8M | ||
| Q4 24 | $15.6M | $46.9M | ||
| Q3 24 | $11.0M | $9.1M | ||
| Q2 24 | $1.0M | $3.0M | ||
| Q1 24 | $11.2M | $2.4M |
| Q4 25 | $14.4M | $59.2M | ||
| Q3 25 | $9.7M | $41.9M | ||
| Q2 25 | $14.1M | $-9.2M | ||
| Q1 25 | $3.6M | $18.8M | ||
| Q4 24 | $15.6M | $41.7M | ||
| Q3 24 | $11.0M | $8.4M | ||
| Q2 24 | $1.0M | $1.4M | ||
| Q1 24 | — | $614.0K |
| Q4 25 | 19.1% | 100.2% | ||
| Q3 25 | 17.7% | 74.3% | ||
| Q2 25 | 26.8% | -16.3% | ||
| Q1 25 | 7.7% | 35.4% | ||
| Q4 24 | 26.4% | 78.8% | ||
| Q3 24 | 13.7% | 16.7% | ||
| Q2 24 | 2.1% | 2.9% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | 0.0% | 5.4% | ||
| Q3 25 | 0.0% | 1.0% | ||
| Q2 25 | 0.0% | 1.6% | ||
| Q1 25 | 0.1% | 1.9% | ||
| Q4 24 | 0.0% | 9.9% | ||
| Q3 24 | 0.0% | 1.2% | ||
| Q2 24 | 0.0% | 3.1% | ||
| Q1 24 | 0.0% | 3.7% |
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | 2.96× | ||
| Q2 25 | 2.41× | -0.54× | ||
| Q1 25 | 1.21× | 1.44× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | 0.81× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | — | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
